SUPN financials
Supernus Pharmaceuticals (SUPN) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
SUPN income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $718.95M | $644.39M | -$36.86M | -$38.55M | -0.68 |
| 2024 | $661.82M | $583.91M | $81.67M | $73.86M | 1.32 |
| 2023 | $607.52M | $523.74M | -$5.27M | $1.32M | 0.02 |
| 2022 | $667.24M | $580.02M | $46.12M | $60.71M | 1.04 |
| 2021 | $579.77M | $504.71M | $86.03M | $53.42M | 0.98 |
| 2020 | $520.40M | $467.94M | $173.70M | $126.95M | 2.36 |
- SUPN revenue was $718.95M in fiscal 2025, net income -$38.55M.
Updated 2026-11-02 19:55 UTC